Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - ACCOUNTS PAYABLE
Accounts Payable FOLD - Amicus Therapeutics, Inc.
15.1 M
LAST VALUE
-16.16%
2 YEAR CAGR
18.01%
5 YEAR CAGR
21.56%
10 YEAR CAGR